Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
WEC Energy
WEC
$34.5B
| $863K | ﹤0.01% |
7,389
-307,901
| -98% | -$35.1M |
|
2202
Lloyds Banking Group
LYG
$87.3B
| $863K | ﹤0.01% |
147,979
-600,773
| -80% | -$3.26M |
|
2203
PUT
Emerson Electric
EMR
$87.7B
| $859K | ﹤0.01% |
+6,000
| New | +$845K |
|
2204
Assured Guaranty
AGO
$3.27B
| $858K | ﹤0.01% |
+10,699
| New | +$845K |
|
2205
AAR Corp
AIR
$5.43B
| $857K | ﹤0.01% |
+5,996
| New | +$708K |
|
2206
Kyverna Therapeutics
KYTX
$521M
| $856K | ﹤0.01% |
96,048
-1,029,273
| -91% | -$9.14M |
|
2207
PUT
Agnico Eagle Mines
AEM
$109B
| $853K | ﹤0.01% |
5,500
+4,500
| +450% | +$834K |
|
2208
Iron Mountain
IRM
$36.3B
| $852K | ﹤0.01% |
6,749
-121,943
| -95% | -$14.9M |
|
2209
PUT
Elevance Health
ELV
$86.9B
| $851K | ﹤0.01% |
+2,200
| New | +$816K |
|
2210
Build-A-Bear
BBW
$488M
| $848K | ﹤0.01% |
+27,708
| New | +$994K |
|
2211
Emcor
EME
$34.3B
| $846K | ﹤0.01% |
1,020
-314
| -24% | -$266K |
|
2212
PUT
Dow Inc
DOW
$23.4B
| $845K | ﹤0.01% |
30,900
+2,800
| +10% | +$102K |
|
2213
PBF Energy
PBF
$8.72B
| $845K | ﹤0.01% |
18,571
-198,527
| -91% | -$8.26M |
|
2214
PUT
Phillips 66
PSX
$96.9B
| $845K | ﹤0.01% |
5,000
-8,700
| -64% | -$1.5M |
|
2215
Icon
ICLR
$13.3B
| $844K | ﹤0.01% |
4,859
-131,557
| -96% | -$16.7M |
|
2216
Stevanato
STVN
$6.17B
| $840K | ﹤0.01% |
46,495
-281,156
| -86% | -$4.75M |
|
2217
CenterPoint Energy
CNP
$25.5B
| $839K | ﹤0.01% |
19,050
+9,305
| +95% | +$399K |
|
2218
PUT
Agilent Technologies
A
$44.9B
| $837K | ﹤0.01% |
+6,300
| New | +$768K |
|
2219
Biglari Holdings Class A
BH.A
$1.24B
| $831K | ﹤0.01% |
395
-463
| -54% | -$760K |
|
2220
PUT
Hewlett Packard
HPE
$70.8B
| $830K | ﹤0.01% |
+18,400
| New | +$664K |
|
2221
EnerSys
ENS
$6.84B
| $829K | ﹤0.01% |
3,547
+876
| +33% | +$190K |
|
2222
PUT
Ally Financial
ALLY
$13.1B
| $827K | ﹤0.01% |
+18,000
| New | +$781K |
|
2223
Forte Biosciences
FBRX
$1.63B
| $827K | ﹤0.01% |
38,898
+20,181
| +108% | +$479K |
|
2224
Kimberly-Clark
KMB
$36.4B
| $827K | ﹤0.01% |
7,530
-861
| -10% | -$85.3K |
|
2225
PUT
Alcoa
AA
$13.7B
| $824K | ﹤0.01% |
+15,800
| New | +$1.06M |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.